Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales

European Respiratory Journal

Volumn 10, Issue 7, 1997, Pages 1552-1558

  Crook, A ^a   Duffy, A ^a   Girling, D J ^a   Souhami, R L ^b   Parmar, M K B ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Multi modality treatment; Non small cell lung cancer; Radiotherapy; Treatment survey

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MEDICAL SPECIALIST; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT PLANNING; UNITED KINGDOM;

AGED; ATTITUDE OF HEALTH PERSONNEL; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; ENGLAND; HUMANS; LUNG NEOPLASMS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUESTIONNAIRES; WALES;

EID: 0030743009     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10071552     Document Type: Article

References (19)

1. Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991; 51: 253-261 .
2. Souhami RL. Current issues in cancer: lung cancer. BMJ 1992; 304: 1298-1301.
3. Tsang GMK, Watson DCT. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. Thorax 1992; 47: 3-5.
4. Muers MF. Preoperative screening for metastases in lung cancer. Thorax 1994; 49: 1-2.
5. Carroll M, Morgan SA, Yarnold JR, Hill JM, Wright NM. Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol 1986; 22: 1353-1356.
6. Macbeth FR, Bolger J. Palliative radiotherapy for bronchial carcinoma: science or art? Clin Oncol 1991; 3: 245-246.
7. Aisner J, Belani CP. Lung cancer: recent changes and expectations of improvements. Semin Oncol 1992; 20: 383-393.
8. Johnson DH. Chemotherapy for stage III non-small cell lung cancer. Lung Cancer 1994; 11 (Suppl. 2): 148-150.
9. Talbot DC, Smith IE. New drugs in lung cancer. In: Thatcher N, Spiro S, eds. New Perspectives in Lung Cancer. London, British Medical Journal Publishing Group, 1994; pp. 143-160.
10. Report of a Working Group to the Standing Medical Advisory Committee (Department of Health). The management of lung cancer: current clinical practices, 1994.
11. Smith IE. Palliative chemotherapy for advanced non-small cell lung cancer: time to reappraise its role. BMJ 1994; 308: 429-430.
12. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a metaanalysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
13. Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non-small cell lung cancer. J Clin Oncol 1995; 13: 1904-1911.
14. Slevin ML, Stubbs L, Plant HJ, et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990; 300: 1458-1460.
15. Brundage MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 1997; 15: 330-340.
16. Rosell R, Gómez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330: 153-158.
17. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86: 673-680.
18. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-423.
19. Evans WK, Will BP, Berthelot J-M, Wolfson M. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs. Br J Cancer 1995; 72: 1270-1277.